These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art. Popescu C; Burger IA Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789 [TBL] [Abstract][Full Text] [Related]
7. Updates in Cardiac Amyloidosis Diagnosis and Treatment. Stern LK; Kittleson MM Curr Oncol Rep; 2021 Mar; 23(4):47. PubMed ID: 33725199 [TBL] [Abstract][Full Text] [Related]
8. Imaging cardiac amyloidosis: an opportunity for nuclear cardiology. Dorbala S J Nucl Cardiol; 2014 Dec; 21(6):1043-4. PubMed ID: 25367453 [No Abstract] [Full Text] [Related]
9. Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy. Yang M; Arsanjani R; Roarke MC AJR Am J Roentgenol; 2020 Nov; 215(5):1208-1217. PubMed ID: 32901569 [No Abstract] [Full Text] [Related]
10. Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers. Hotta M; Minamimoto R; Awaya T; Hiroe M; Okazaki O; Hiroi Y Radiographics; 2020; 40(7):2029-2041. PubMed ID: 32976061 [TBL] [Abstract][Full Text] [Related]
11. Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis. Castano A; Haq M; Narotsky DL; Goldsmith J; Weinberg RL; Morgenstern R; Pozniakoff T; Ruberg FL; Miller EJ; Berk JL; Dispenzieri A; Grogan M; Johnson G; Bokhari S; Maurer MS JAMA Cardiol; 2016 Nov; 1(8):880-889. PubMed ID: 27557400 [TBL] [Abstract][Full Text] [Related]
12. Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week. Hanna M; Ruberg FL; Maurer MS; Dispenzieri A; Dorbala S; Falk RH; Hoffman J; Jaber W; Soman P; Witteles RM; Grogan M J Am Coll Cardiol; 2020 Jun; 75(22):2851-2862. PubMed ID: 32498813 [TBL] [Abstract][Full Text] [Related]
13. Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities. Orini M; Graham AJ; Martinez-Naharro A; Andrews CM; de Marvao A; Statton B; Cook SA; O'Regan DP; Hawkins PN; Rudy Y; Fontana M; Lambiase PD J Am Heart Assoc; 2019 Sep; 8(18):e012097. PubMed ID: 31496332 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic Work-Up of Cardiac Amyloidosis Using Cardiovascular Imaging: Current Standards and Practical Algorithms. Korosoglou G; Giusca S; André F; Aus dem Siepen F; Nunninger P; Kristen AV; Frey N Vasc Health Risk Manag; 2021; 17():661-673. PubMed ID: 34720583 [TBL] [Abstract][Full Text] [Related]
15. Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [ Minutoli F; Russo M; Di Bella G; Laudicella R; Spataro A; Vento A; Comis A; Gentile L; Mazzeo A; Vita G; Baldari S Eur Radiol; 2022 May; 32(5):3035-3044. PubMed ID: 35031838 [TBL] [Abstract][Full Text] [Related]
17. Varying levels of small microcalcifications and macrophages in ATTR and AL cardiac amyloidosis: implications for utilizing nuclear medicine studies to subtype amyloidosis. Stats MA; Stone JR Cardiovasc Pathol; 2016; 25(5):413-7. PubMed ID: 27469499 [TBL] [Abstract][Full Text] [Related]